In depth
Sjogren's disease: common questions
This is a small research field, and knowing how small it is changes how you read the advice you're given. Six exercise trials and ten human diet studies is the whole of it. What follows says which findings come from Sjogren's studies and how heavily each of them needs qualifying.
What the research found.
Pooling the entire randomized exercise literature in Sjogren's disease gives 6 trials and 277 participants, which is the whole of it. Standardized mean differences came out at 0.69 for functional capacity, 0.59 for cardiopulmonary function, and 0.51 for vitality. Those are moderate effects on the outcomes exercise usually moves.
In that same pooled analysis, the effect on disease activity measured by ESSDAI came out at negative 0.09. Its confidence interval ranged from negative 0.41 to 0.23. The effects on pain and fatigue didn't reach significance either, so the disease score is the thing exercise leaves alone.
In 104 people randomized to omega-3 or placebo for two months, dry eye symptoms fell from 10.44 to 4.85 on an 18-point scale. The placebo group fell to 8.27 over the same period. The Schirmer tear test improved substantially in both groups, which is the part most summaries leave out.
Al-Rawi and colleagues, Mediterranean Journal of Rheumatology, 2025
Obstructive sleep apnea occurred at roughly twice the frequency in primary Sjogren's syndrome as it did in healthy controls. The figures were 64 percent in patients against 28 percent in controls. Total sleep time across the studied populations ranged from 5.2 to 7 hours, which is short by any standard.
A small field, and why that counts
The research base in Sjogren's disease is smaller than in any other condition covered on this site. The entire randomized exercise literature is 6 trials and 277 participants between them. The nutrition literature is 10 human studies, and most of those are case reports and case series rather than controlled trials.
Knowing the size of that field changes how you read everything else. Advice given confidently about exercising or eating with this diagnosis is drawing on considerably more than exists. Most of it is borrowed from other conditions, and the borrowing is almost never mentioned to the person being advised.
It also explains why the answers below are more heavily qualified than they would be for a commoner disease. That isn't hedging, and it's an accurate description of the field as it stands. The largest randomized trial in this condition enrolled 60 people, and only 28 of those people completed the exercise protocol.
Exercise, which improves function and not disease activity
The pooled analysis of all 6 randomized trials found consistent improvements on the outcomes exercise usually moves. Functional capacity came out at a standardized mean difference of 0.69, cardiopulmonary function at 0.59, vitality at 0.51, general health status at 0.46, and mental health at 0.42. Certainty was rated moderate for functional capacity and vitality, and low for the others.
Disease activity didn't move. The pooled effect on the EULAR index was negative 0.09 with a confidence interval from negative 0.41 to 0.23, and that particular finding came with moderate certainty, which makes it one of the more dependable numbers in the set. A trial of 60 women reached the same conclusion independently, finding no between-group difference on disease activity despite a clear difference in fitness.
Pain and fatigue are in between and neither reached significance in the pooled analysis. Individual trials are more encouraging on fatigue, with a walking trial finding a significant benefit and a narrative review reporting improvement in all three studies that measured it. Reporting both readings is the honest thing, and the pooled one is the cautious one.
The one nutrition trial, and what it found
The only properly blinded, placebo-controlled nutrition trial of reasonable size in this condition randomized 104 people to omega-3 or placebo for two months. Dry eye symptoms fell from 10.44 to 4.85 on an 18-point scale against 8.27 on placebo, at a P value of 0.001. Dry mouth scores improved on the supplement as well.
The objective measurements complicate that picture in a way summaries leave out. The Schirmer tear test rose from 2.38 to 6.63 millimetres on omega-3 and from 2.68 to 5.58 millimetres on placebo, so both groups improved substantially. Saliva production came out at a P value of 0.053, which doesn't clear the conventional threshold.
So the supplement's advantage appears in how people felt rather than in how much they produced. Feeling less dry is a legitimate goal and it's what most people want from treatment. It's also a different claim from restoring gland function, and this trial supports the first of those considerably better than the second.
Sleep, which is the least discussed problem here
A systematic review of sleep in primary Sjogren's syndrome found patients reporting significantly greater subjective sleep disturbance, more daytime sleepiness, and more frequent night awakenings than controls. Total sleep time across the included populations ranged from 5.2 to 7 hours. That's a short night by any standard, and it is accompanied by a fatigue burden that goes unmeasured.
The finding worth acting on is the sleep apnea figure. Obstructive sleep apnea occurred at roughly twice the frequency in primary Sjogren's as in healthy controls, at 64 percent against 28 percent, at a P value of 0.03. That's a diagnosable and treatable problem, which puts it in a different category from most of what's on this page.
What has never been done is a test of any intervention for sleep in this condition. The review's own conclusion was that interventions targeted at sleep difficulties in primary Sjogren's warrant further investigation, which is the polite way of saying there aren't any. That leaves the sleep apnea question as the practical route in, and it's worth raising specifically, because tiredness in general gets nowhere.
What to raise at an appointment
The disease activity index in Sjogren's measures organ involvement rather than dryness, which is a useful clue about what your rheumatologist is watching for. New breathlessness or a persistent cough, numbness or tingling, gland swelling, and unexplained fever all belong in an appointment for that reason. So does any change in the look of your urine.
Sleep and fatigue belong there too and get raised far less often. Both are common enough here to be near-universal, and both are treated as inevitable by patients and clinicians alike. One of the two has a treatable cause in a majority of people, according to that review.
Dryness itself is worth mentioning to your dentist as well as to your rheumatologist. Reduced saliva removes a protection against decay that goes unnoticed until it's gone, which changes how often you should be seen and what a dentist looks for. That's the most practical single sentence on this page.
Common misconceptions.
Myth. Sjogren's is just dry eyes and dry mouth.
Reality. Dryness is the most visible part and the disease is systemic. It can involve the lungs, the kidneys, and the nerves, it brings a fatigue burden that dominates many people's experience, and its disease activity index measures organ involvement rather than dryness. Sleep, fatigue, and function are where much of the impact sits.
Myth. Exercise will bring my disease activity down.
Reality. The pooled effect on disease activity across the whole randomized literature was negative 0.09, with a confidence interval from negative 0.41 to 0.23, and that finding came with moderate certainty. Exercise is worth doing here for fitness, function, and vitality, where the pooled effects ranged from 0.42 to 0.69. Expecting a lower disease score is what will disappoint you.
Myth. Omega-3 restores tear production.
Reality. It improved symptoms clearly against placebo in the one blinded trial, and the objective measurement improved in both groups. Schirmer results rose from 2.38 to 6.63 mm on omega-3 and from 2.68 to 5.58 mm on placebo, and saliva production came out at a P value of 0.053. The symptom benefit is solid and the secretion benefit isn't.
Myth. There's a body of research telling me what to do.
Reality. There are six randomized exercise trials totalling 277 people and ten human diet studies, most of them case reports. That's the whole field. Any confident prescription for Sjogren's specifically is drawing on considerably more than exists, and knowing that is useful when you're offered one.
Questions patients ask.
How much research exists on lifestyle in Sjogren's?
Less than in almost any other condition covered on this site, which is worth saying first. The entire randomized exercise literature here is 6 trials and 277 participants. The nutrition literature is 10 human studies, most of them case reports and case series rather than trials. For comparison, a single moderate trial in rheumatoid arthritis often enrolls more people than the whole exercise literature here.
What does exercise improve?
Fitness and function are what improve most clearly here. Pooled standardized mean differences were 0.69 for functional capacity, 0.59 for cardiopulmonary function, 0.51 for vitality, 0.46 for general health status, and 0.42 for mental health. Certainty was rated moderate for functional capacity and vitality and low for the rest. Those are moderate effects on the outcomes exercise usually moves rather than a surprise.
Will it help my fatigue?
The pooled figure didn't reach significance, at negative 0.57 with a confidence interval from negative 1.57 to 0.44 and heterogeneity of 85 percent. Individual trials are friendlier, with fatigue improving more than control in all three studies measuring it in one review, and a walking trial finding a significant benefit. The pooled result is the more conservative reading and both are honest.
Does exercise change my disease activity?
No, on the evidence available, and the pooled figure says so plainly. The pooled effect on the EULAR disease activity index was negative 0.09 with a confidence interval from negative 0.41 to 0.23, and that finding came with moderate certainty. A trial of 60 women likewise found no between-group difference on disease activity despite a clear difference in fitness. Exercise here isn't a disease-modifying treatment, and nothing suggests it is.
Does omega-3 help dry eyes?
It's the one nutritional thing here with a proper trial behind it. In 104 people randomized to omega-3 or placebo for two months, dry eye symptoms fell from 10.44 to 4.85 on an 18-point scale against 8.27 on placebo, at a P value of 0.001. The objective tear test improved substantially in both groups, so the advantage appears in how people felt rather than in what they produced.
Is there a Sjogren's diet?
No tested one. This site holds one nutrition trial in this disease and nothing else of any size, so there's no body of evidence to draw specific recommendations for managing oral symptoms from. Several of the encouraging findings in it come from three to five people with no control group. A separate cross-sectional study found Mediterranean adherence correlating with less ocular dryness, which can't establish direction.
Why am I so tired, and why is my sleep so bad?
Sleep in this condition is markedly worse than in controls and it's under-discussed. People with primary Sjogren's reported significantly greater sleep disturbance, more daytime sleepiness, and more frequent night awakenings, and obstructive sleep apnea occurred at roughly twice the frequency, at 64 percent against 28 percent. Total sleep time across the studied groups ranged from 5.2 to 7 hours.
What can be done about the sleep problem?
Nothing has been tested in this condition, which the review that documented the problem says itself. Its authors concluded that interventions targeted at sleep difficulties in primary Sjogren's warrant further investigation, meaning no such study has been done. The sleep apnea figure is the actionable part, because that's a diagnosable and treatable problem and it's twice as common here as in controls.
Does what I eat affect my teeth?
This is the part of the subject with the most practical weight and the least controversy. Reduced saliva removes a protection against decay that most people never think about, which makes how often you eat sugar more important than how much. Regular dental care counts more here than for other people, and telling your dentist you have Sjogren's changes what they look for.
What should I take to my next appointment?
Anything outside the dryness, because that's what the disease activity index measures. New breathlessness or a persistent cough, numbness or tingling, swelling of the glands, unexplained fever, and any change in your urine all belong there. So do sleep and fatigue, given how common the first is and how little of it gets raised.
References.
- Gao Q; Fan C; Zhang Y et al. Effects of physical activity on health-related outcomes in Sjögren’s syndrome: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Immunology. 2026;17. 10.3389/fimmu.2026.1753791Systematic review and meta-analysis of RCTs
- Ayán-Pérez C; Carballo-Afonso R; Bueno-Russo R et al. Is Physical Exercise Beneficial for People with Primary Sjögren’s Syndrome? Findings from a Systematic Review. Applied Sciences. 2025;15:1455. 10.3390/app15031455Systematic review
- Garcia A; Dardin L; Minali P et al. Cardiovascular Effect of Physical Exercise on Primary Sjogren's Syndrome (pSS): Randomized Trial. Frontiers in Medicine. 2021;8. 10.3389/fmed.2021.719592Randomised controlled trial
- Miyamoto S; Valim V; Carletti L et al. Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren’s syndrome: a randomized-controlled trial. Rheumatology International. 2019;39:227-238. 10.1007/s00296-018-4213-zRandomised controlled trial
- Al-Rawi Z; Jalal A; Hameed I. A Randomised Double-Blind Placebo-Controlled Clinical Trial of Fish Oil (Omega-3) in Sjögren’s Syndrome Patients in Erbil-Iraq. Mediterranean Journal of Rheumatology. 2025;36:92. 10.31138/mjr.090224.rdbRandomised
- Chaaya C; Raad E; Kahale F et al. Adherence to Mediterranean Diet and Ocular Dryness Severity in Sjögren’s Syndrome: A Cross-Sectional Study. Medical Sciences. 2025;13:64. 10.3390/medsci13020064Cross-sectional observational study
- Hackett K; Gotts Z; Ellis J et al. An investigation into the prevalence of sleep disturbances in primary Sjögren’s syndrome: a systematic review of the literature. Rheumatology. 2016:kew443. 10.1093/rheumatology/kew443Systematic review
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.